431 POSTER A phase I first-in-human study of the polo-like kinase 1-selective inhibitor, GSK461364, in patients with advanced solid tumors

Sarah P. Blagden, Johann S. de Bono, D. Smith et al.|European Journal of Cancer Supplements|2008

Cited by 4